ATE329591T1 - Verbindung eines antithrombotischen mittels mit aspirin und dessen verwendung zur behandlung von atherothrombotischen erkrankungen - Google Patents
Verbindung eines antithrombotischen mittels mit aspirin und dessen verwendung zur behandlung von atherothrombotischen erkrankungenInfo
- Publication number
- ATE329591T1 ATE329591T1 AT03745819T AT03745819T ATE329591T1 AT E329591 T1 ATE329591 T1 AT E329591T1 AT 03745819 T AT03745819 T AT 03745819T AT 03745819 T AT03745819 T AT 03745819T AT E329591 T1 ATE329591 T1 AT E329591T1
- Authority
- AT
- Austria
- Prior art keywords
- antithrbotic
- aspirin
- agent
- treatment
- combination
- Prior art date
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title 1
- 229960001138 acetylsalicylic acid Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0204222A FR2838057B1 (fr) | 2002-04-05 | 2002-04-05 | Nouvelle association d'un antithrombotique et d'aspirine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE329591T1 true ATE329591T1 (de) | 2006-07-15 |
Family
ID=28052120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03745819T ATE329591T1 (de) | 2002-04-05 | 2003-04-04 | Verbindung eines antithrombotischen mittels mit aspirin und dessen verwendung zur behandlung von atherothrombotischen erkrankungen |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7618955B2 (https=) |
| EP (1) | EP1496884B1 (https=) |
| JP (1) | JP4065853B2 (https=) |
| KR (1) | KR100645143B1 (https=) |
| CN (1) | CN1297265C (https=) |
| AR (1) | AR039253A1 (https=) |
| AT (1) | ATE329591T1 (https=) |
| AU (1) | AU2003246774B2 (https=) |
| BR (1) | BR0309019A (https=) |
| CA (1) | CA2480697A1 (https=) |
| CY (1) | CY1105106T1 (https=) |
| DE (1) | DE60306133T2 (https=) |
| DK (1) | DK1496884T3 (https=) |
| EA (1) | EA006978B1 (https=) |
| ES (1) | ES2264533T3 (https=) |
| FR (1) | FR2838057B1 (https=) |
| GE (1) | GEP20074101B (https=) |
| MA (1) | MA27114A1 (https=) |
| MX (1) | MXPA04009760A (https=) |
| NO (1) | NO20044700L (https=) |
| NZ (1) | NZ535430A (https=) |
| PL (1) | PL371620A1 (https=) |
| PT (1) | PT1496884E (https=) |
| UA (1) | UA79457C2 (https=) |
| WO (1) | WO2003084525A1 (https=) |
| ZA (1) | ZA200407593B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SMP200800012B (it) * | 2005-07-22 | 2008-02-27 | Procter & Gamble | Composizioni per ridurre l'incidenza di aritmia indotta da farmaco |
| EP2155195B1 (en) * | 2007-04-13 | 2014-07-16 | Millennium Pharmaceuticals, Inc. | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
| JP2009001537A (ja) * | 2007-06-25 | 2009-01-08 | Lab Servier | 血管障害の処置を目的とする医薬の入手における抗アテローム血栓化合物の使用 |
| FR2920772B1 (fr) * | 2007-09-11 | 2009-10-23 | Servier Lab | Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2711139B1 (fr) * | 1993-10-15 | 1995-12-01 | Adir | Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
2002
- 2002-04-05 FR FR0204222A patent/FR2838057B1/fr not_active Expired - Fee Related
-
2003
- 2003-04-04 EP EP03745819A patent/EP1496884B1/fr not_active Expired - Lifetime
- 2003-04-04 DE DE60306133T patent/DE60306133T2/de not_active Expired - Fee Related
- 2003-04-04 JP JP2003581765A patent/JP4065853B2/ja not_active Expired - Fee Related
- 2003-04-04 DK DK03745819T patent/DK1496884T3/da active
- 2003-04-04 AU AU2003246774A patent/AU2003246774B2/en not_active Ceased
- 2003-04-04 MX MXPA04009760A patent/MXPA04009760A/es active IP Right Grant
- 2003-04-04 AT AT03745819T patent/ATE329591T1/de not_active IP Right Cessation
- 2003-04-04 PL PL03371620A patent/PL371620A1/xx not_active Application Discontinuation
- 2003-04-04 UA UA20041109009A patent/UA79457C2/uk unknown
- 2003-04-04 PT PT03745819T patent/PT1496884E/pt unknown
- 2003-04-04 EA EA200401293A patent/EA006978B1/ru not_active IP Right Cessation
- 2003-04-04 NZ NZ535430A patent/NZ535430A/en unknown
- 2003-04-04 AR ARP030101180A patent/AR039253A1/es unknown
- 2003-04-04 ES ES03745819T patent/ES2264533T3/es not_active Expired - Lifetime
- 2003-04-04 KR KR1020047015845A patent/KR100645143B1/ko not_active Expired - Fee Related
- 2003-04-04 WO PCT/FR2003/001054 patent/WO2003084525A1/fr not_active Ceased
- 2003-04-04 US US10/509,605 patent/US7618955B2/en not_active Expired - Fee Related
- 2003-04-04 CN CNB038078619A patent/CN1297265C/zh not_active Expired - Fee Related
- 2003-04-04 BR BR0309019-1A patent/BR0309019A/pt not_active IP Right Cessation
- 2003-04-04 GE GEAP8486A patent/GEP20074101B/en unknown
- 2003-04-04 CA CA002480697A patent/CA2480697A1/fr not_active Abandoned
-
2004
- 2004-09-21 ZA ZA200407593A patent/ZA200407593B/xx unknown
- 2004-10-29 NO NO20044700A patent/NO20044700L/no not_active Application Discontinuation
- 2004-11-03 MA MA27925A patent/MA27114A1/fr unknown
-
2006
- 2006-07-24 CY CY20061101027T patent/CY1105106T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
| DE602004010407D1 (de) | Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden | |
| ATE389649T1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
| DE602004017588D1 (de) | 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen | |
| DE60324777D1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
| DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
| ATE551100T1 (de) | Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen | |
| DE60335293D1 (de) | Pyrrolopyridazin-verbindungen und verwendungsverfahren dafür zur behandlung von proliferativen erkrankungen | |
| ATE462708T1 (de) | Zur behandlung von hyperproliferationserkrankungen und mit angiogenese assoziierten krankheiten geeignete pyrrolotriazinderivate | |
| EP1896083A4 (en) | METHOD FOR TREATING PUMP DISEASE USING 1-DEOXYNOJIRIMYCIN AND ITS DERIVATIVES | |
| DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
| DE60327622D1 (de) | Kombinierte antitachykardie - schrittmacher und hochspannungstherapie zur behandlung von ventrikulären arrhythmien | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE602006018583D1 (de) | Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten | |
| DE60224163D1 (de) | Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen | |
| DE60223715D1 (de) | Glyt1 transporter inhibitoren und deren anwendung in der behandlung von neurologischen und neuropsychiatischen krankheiten | |
| ATE413385T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| DE60328517D1 (de) | Neue verwendung von lycopin zur behandlung von erkrankungen im zusammenhang mit androgenwirkung | |
| ATE374204T1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| DE602004010708D1 (de) | Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen | |
| EP1487446A4 (en) | BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE296628T1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| IS7348A (is) | N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1496884 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |